相关实验视频

Updated: May 9, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

最近在恶性乳腺瘤的进展

¹Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul, Korea. silvershoe99@gmail.com.

Journal of breast cancer

|May 2, 2025

概括

基因组的洞察力揭示了良性和恶性植物瘤 (PTs) 之间的关键差异. 了解这些分子驱动因素,如MED12和TP53突变,对于开发针对性治疗恶性PTs至关重要.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

乳腺瘤 (Phyllodes tumors,PTs) 是一种罕见的乳腺纤维皮质瘤.
诊断依赖于组织病理学,但分子基础越来越被理解.
恶性PTs (MPTs) 需要不同的诊断和治疗考虑.

研究的目的:

在PT中审查和整合当前的基因组和分子发现.
阐明分子特征,区分良性和恶性PT.
确定潜在的治疗目标和未来的研究方向.

主要方法:

基因组和分子研究的全面审查.
对基因突变 (MED12,TERT,TP53) 和放大 (EGFR) 的分析.
整合转录基因数据和患者衍生模型.

主要成果:

在良性PT中,MED12突变很常见.
TERT促进物,TP53变化和EGFR放大与恶性转变有关.
鉴定了MPT的不同分子亚型,突出显示了异质性.
失调的信号通路 (PI3K/Akt/mTOR,MET,IGF1R) 提供治疗点.

结论:

分子分析提高了对PT进展和异质性的理解.
基因组改变为MPT治疗提供了潜在的点.
挑战包括内异质性和稀有性,需要综合的奥米克和协作研究.

关键词:

遗传变异是一种遗传变异.分子向疗法分子向疗法这种类型的瘤是Phyllodes瘤.

更多相关视频

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...